Pseudomonas syringae pv. Phaseolicola uses distinct modes of stationary-phase persistence to survive bacteriocin and streptomycin treatments

Keyphrases

• Persisters 100%
• Bacteriocin 100%
• Pseudomonas Syringae 100%
• Stationary Phase 100%
• Streptomycin 100%
• Tailocin 90%
• Dormant 30%
• Antibiotics 20%
• Metabolic Activity 20%
• Redox 20%
• Redox State 20%
• Recurring 10%
• Highly Effective 10%
• Control Method 10%
• Survivors 10%
• Physiological Condition 10%
• Infection Cycle 10%
• Virulence 10%
• Antimicrobial Therapy 10%
• Combination Treatment 10%
• Physiological Characteristics 10%
• Plant Host 10%
• Plant Pathogen 10%
• Metabolic State 10%
• Small Fraction 10%
• Unculturable 10%
• Culturable 10%
• Biocontrol 10%
• Small Populations 10%
• Intact Cells 10%
• Biological Control 10%
• Treatment Results 10%
• Membrane Permeability 10%
• Heterogeneous Population 10%
• Biological Products 10%
• Recurrent Infection 10%
• Non-culturable 10%
• Metabolic Signaling 10%
• Animal Hosts 10%
• Dormant Cells 10%
• Redox Sensing 10%
• Tolerant Cells 10%
• Antibiotic Persistence 10%
• Dormant Bacteria 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Bacteriocin 100%
• Streptomycin 100%
• Pseudomonas syringae 100%
• Infection 28%
• Antibiotics 14%
• Antiinfective Agent 14%
• Recurrent Infection 14%
• Diseases 14%
• Plant Diseases 14%

Immunology and Microbiology

• Pseudomonas syringae 100%
• Infectious Agent 50%
• Metabolism 50%
• Membrane Permeability 50%